Skip to main content
The George Institute for Global HealthThe George Institute for Global Health
Covid-19
Donate

Social links India

  • Facebook
  • Twitter
  • YouTube
The George Institute for Global Health
  • About us
    • Our Mission And Values
    • Our Strategy
    • Our History
    • How Our Research Is Different
    • Our People
    • Board Of Directors
    • Global Advisory Committee (ACRIS)
    • George Health
    • Annual Reports
    • Financial Statements
  • Our Work
    • Our Priorities
    • Better Treatments
    • Better Care
    • Healthier Societies
    • Ongoing Projects
    • Archived Projects
    • Publications
  • News & Events
    • Media Releases
    • News Stories
    • Media Coverage
    • Media Enquiries
    • Events
    • Past Events
    • Blogs / Profile Stories
    • E-Newsletters
    • Videos
    • Podcasts
  • Our Impact
    • Reports And Recommendations
    • Case Studies And Examples
    • Advocacy And Thought Leadership
    • Disruptive Social Entrepreneurship
  • Careers & studies
    • The George Experience
    • Research Training Programs
    • Current Job Opportunities
  • Thought leadership
    • Better Treatments
    • Better Care
    • Healthier Societies
    • Disruptive Social Entrepreneurship
    • Distinguished Fellows
    • Activities
  • Contact Us
  • Get involved
    • Building Back Better After COVID-19: The Research Agenda
    • Reclaiming Comprehensive Public Health: A Call to Action
    • Universal Health Coverage: A Call To Action
    • Donate
  • Donate
  1. Home

Mohammad Abdul Salam

India

Senior Research Fellow Lecturer, Faculty of Medicine, UNSW Sydney

M Pharm, PHD

Salam is a Senior Research Fellow at The George Institute for Global Health India. Salam holds a Masters in Pharmacy (Pharmacology) and a PhD in Medicine from The University of Sydney, Australia.

His research focus includes control of cardio-metabolic risk factors and in particular clinical trials in testing simple and cost-effective interventions for the prevention and treatment of cardiovascular diseases. 

Further Reading

  • National Symposium on Evidence Synthesis for Medicine & Public Health

    NESE 2020
  • Evidence maps for identifying research gaps: Leptospirosis in India

  • Use of a multidrug pill in reducing cardiovascular events (UMPIRE)

Recent Publications

  • Association of Low-Dose Triple Combination Therapy with Therapeutic Inertia and Prescribing Patterns in Patients with Hypertension: A Secondary Analysis of the TRIUMPH Trial

  • Two-drug fixed-dose combinations of blood pressure-lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost

  • Regression to the mean in home blood pressure: Analyses of the BP GUIDE study

  • Strategic, Successful, and Sustained Synergy: The Global Alliance for Chronic Diseases Hypertension Program

  • Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial

View all publications
  • About us
  • Our Work
  • News & Events
  • Our Impact
  • Careers & studies
  • Get involved
  • Thought leadership
  • Contact us
  • Donate

The George Institute for Global Health

308-309, Third Floor, Elegance Tower, Plot No. 8, Jasola District Centre
New Delhi 110025 India
Tel: +91 11 415 880 91-93
Fax: +91 11 415 880 90
info@georgeinstitute.org.in

The George Institute country sites:

  • The George Institute country sites:
  • Australia
  • China
  • India
  • UK

Social links India

  • Facebook
  • Twitter
  • YouTube

Subscribe to our E-newsletter

Copyright © 2021 The George Institute

Footer Links

  • Disclaimer
  • Privacy policy
  • Data sharing policy
  • Whistleblower policy
  • Modern slavery statement
  • Research code policy
  • Sitemap